This inventor holds 3 USPTO granted patents. Top assignees: Idemitsu Kosan Company, Limited, Ajinomoto Co., Ltd.. Active years: 1984-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1999
Title: Innovations by Toshio Kudo in Human Lymphocyte Production
Introduction
Toshio Kudo is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of human lymphocytes and monoclonal antibodies. With a total of 3 patents to his name, Kudo's work has the potential to impact medical research and therapeutic applications.
Latest Patents
Kudo's latest patents focus on methods for producing human lymphocytes and human monoclonal antibodies. One of his inventions describes a method for producing a human lymphocyte that generates an antibody specific to a desired antigen. This process involves transplanting human lymphocytes into an immunodeficient animal, immunizing the animal with the desired antigen, and recovering the human lymphocytes that produce the specific antibody. Additionally, he has developed a method for isolating a human lymphocyte producing an antibody, which includes similar steps of transplantation and immunization, followed by the recovery of lymphocytes through centrifugation.
Career Highlights
Throughout his career, Toshio Kudo has worked with prominent companies such as Idemitsu Kosan Company, Limited and Ajinomoto Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Kudo has collaborated with notable colleagues, including Shuichi Hiyamuta and Toshiyuki Tanedani. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Toshio Kudo's innovative work in the production of human lymphocytes and monoclonal antibodies showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing medical research and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

